A few hours ago, a very good report emerged from the American food and drug administration stating that an HIV/AIDS vaccine has finally been discovered and approved by the agency. According to the report, the American food and drug administration has already approved that this vaccine will be given to people living with HIV only twice a year.
Photo courtesy, image strictly used for evidence purposes only.
This vaccine will help many people living with HIV for they no longer have to keep taking the ARV drugs that they take daily. This vaccine serves as hope that HIV cure will soon be discovered by these brilliant medical researchers.
Photo courtesy, the image of the vaccine, image used for illustration purposes only.
Please share your thoughts on this HIV/AIDS vaccine that will be administered to HIV-positive people twice a year in the comments section below. Please do like, comment and share.
Content created and supplied by: BM-News (via Opera
News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform
See More
COMMENTS